Kettering Health Network (ketteringhealth.org)
Kettering Health Network Logo
Kettering Health Network Logo
Follow FaceBook Follow YouTube Follow Twitter Follow LinkedIn Share

A- A A+ Text Size

Patients & Community

Patients

Interested in Participating?
Contact Us Now!
We participate in research to support the scientific and medical community in the advancement of medicine. Patients may be eligible for additional treatment options by participating in research studies.

The decision to participate in clinical research can be complex and confusing. We strive to provide personal attention to help you navigate through the process.

We also collaborate with the Dayton Clinical Oncology Program (DCOP) to offer National Cancer Institute and other cancer clinical trials right here in the Dayton area. Ask your physician "Is there a clinical trial that is right for me?" or contact us for more information.

The Patient Frequently Asked Questions (FAQ) section provides general information to help you start your clinical research journey. You may also contact us for more information or talk to your physician when interested in research participation.

Physicians

Kettering Health Network also partners with physicians in the community to provide diagnostic and treatment options to patients. There are many active studies that patients may be eligible for.


Studies

Below are a list of the current enrolling studies available through Kettering Health Network. Please click on the clinicaltrials.gov number link for full information on the study, including inclusion/exclusion criteria.


Cancer-Women’s (Ovarian, Fallopian Tube, or Peritoneal)  •  Dr. Thomas Reid  •  NCT03038100
A Phase 3, Multicenter, Randomized, Study of Atezolizumab Versus Placebo Administered in Combination With Paclitaxel, Carboplatin, and Bevacizumab to Patients With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (Imagyn)
Cancer-Uterine  •  Dr. Thomas Reid  •  NCT01533207
A Phase 3 Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) Versus Observation for Uterus-Limited, High-Grade Uterine Leiomyosarcoma (GOG-0277)
Cancer-Cervical  •  Dr. Thomas Reid  •  NCT01101451
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (GOG-0263)
Cancer-Cervical  •  Dr. Thomas Reid  •  NCT02853604
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: (AIM2CERV)
All  •  Dr. Malek Safa  •  NCT03061305
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection (STRATA)
Cancer-Cervical  •  Dr. Thomas Reid  •  NCT03257267
An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator's Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma [EMPOWER GOG 3016]
Cancer-Brain Metastises From Non-small Cell Lung Cancer (NSCLC)  •  Dr. Vijay Kudithipudi  •  NCT02831959
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) (150kHz) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC) [METIS]
Cancer-Ovarian/Peritoneal  •  Dr. Thomas Reid  •  NCT02101788
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer [GOG-0281
Cancer-Ovarian  •  Dr. Thomas Reid  •  NCT03180307
A Phase 3, Randomized, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer


Cardiac-Heart Failure  •  Dr. Franklin Handel  •  NCT02929329
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)
Heart Failure  •  Dr. Franklin Handel  •  NCT03066804
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients (PARALLAX)
Heart Failure  •  Dr. K. Shahid Baig  •  NCT03075215
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Coronary Artery Disease (CAD)  •  Dr. Niranjan Reddy  •  NCT03168776
A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients With Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes [PIONEER III]


Imaging-Nonalcoholic Steatohepatitis (NASH)  •  Dr. Arash Kardan  •  NCT03332940
An Evaluation of the Safety of Intravenous (IV) Tc 99m Tilmanocept and a Comparison of Localization to Tc 99m Sulfur Colloid in Subjects With Nonalcoholic Steatohepatitis (NASH) and Healthy Controls (HC) [NAV-NASH]


Amputation Pain/Phantom Pain  •  Dr. Vivek Manocha  •  NCT02221934
High-Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study [Neuros Pivotal]


Breast Reconstruction  •  Dr. Steven Schmidt  •  NCT02724371
A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction (Athena)


Create your own user feedback survey